
Lonza Group Ltd owns 1 brand in our database. Browse the complete portfolio of Lonza Group Ltd subsidiaries and brands across various industries.
Company Type
public
Headquarters
Basel, Switzerland
Brand Portfolio
1 brands
What is Lonza Group?
It is a Swiss contract development and manufacturing organization, one of the world's largest, producing biologics, small molecules, and advanced therapies for pharmaceutical and biotech customers.
Is Lonza publicly traded?
Yes. It trades on the SIX Swiss Exchange under LONN as a Swiss Market Index constituent, with a secondary listing on the Singapore Exchange.
Who owns Lonza Group?
Its public shareholders. No single controlling owner exists; major institutional holders include BlackRock and Baillie Gifford.
How much revenue does Lonza make?
FY2025 sales were CHF 6.531 billion, with CORE EBITDA of CHF 2.064 billion at a 31.6 percent margin.
Where is Lonza headquartered?
In Basel, Switzerland, since 2022. Its founding and largest site remains Visp in the canton of Valais.
What are Lonza's business platforms?
Integrated Biologics, Advanced Synthesis, and Specialized Modalities, covering biologics, small molecules, cell and gene therapies, and emerging formats.
No competing brands found in the same categories. This could be because Lonza Group Ltdoperates in unique market segments or we're still building our competitor database.
Lonza Group Ltd maintains a diverse portfolio of 1 brands across multiple industries. This comprehensive brand portfolio demonstrates the company's market presence and strategic business units.
For consumers and researchers interested in corporate ownership structures, understanding which brands are owned by Lonza Group Ltdprovides valuable insights into market dynamics, product relationships, and corporate strategy.